Literature DB >> 2732625

Downregulation of tumor necrosis factor expression in the human Mono-Mac-6 cell line by lipopolysaccharide.

J G Haas1, C Thiel, K Blömer, E H Weiss, G Riethmüller, H W Ziegler-Heitbrock.   

Abstract

Mono-Mac-6 cells, but not U937 cells, can be induced to rapidly express tumor necrosis factor (TNF) mRNA and protein when triggered with lipopolysaccharide (LPS) at 1 microgram/ml. Preincubation of the cells for 3 d with low amounts of LPS (10 ng/ml) results in nearly complete suppression of TNF secretion. This downregulation appears to occur at the pretranslational level since specific mRNA is virtually undetectable under these conditions. By contrast, the same preincubation with 10 ng/ml LPS results in enhanced phagocytosis (28.6-67.2% for Staphylococcus aureus), demonstrating that not all monocyte functions are suppressed. While these results show that only stringent exclusion of LPS from culture media allows for induction of TNF in the Mono-Mac-6 cell line, the pronounced effect of LPS preincubation may also provide a suitable model with which to study the mechanisms of LPS-induced desensitization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732625     DOI: 10.1002/jlb.46.1.11

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  VEGF: inflammatory paradoxes.

Authors:  Georges E R Grau; Mike B Thompson; Christopher R Murphy
Journal:  Pathog Glob Health       Date:  2015-09       Impact factor: 2.894

2.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion.

Authors:  H W Ziegler-Heitbrock; M Blumenstein; E Käfferlein; D Kieper; I Petersmann; S Endres; W A Flegel; H Northoff; G Riethmüller; J G Haas
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14.

Authors:  B Neumeister; M Faigle; M Sommer; U Zähringer; F Stelter; R Menzel; C Schütt; H Northoff
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages.

Authors:  J Mathison; E Wolfson; S Steinemann; P Tobias; R Ulevitch
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.

Authors:  M O Labeta; J J Durieux; G Spagnoli; N Fernandez; J Wijdenes; R Herrmann
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

9.  Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A.

Authors:  B E Henricson; C L Manthey; P Y Perera; T A Hamilton; S N Vogel
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages.

Authors:  M Matic; S R Simon
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.